PRC Clinical Supports Regenerative Medicine Research
PRC Clinical, a CRO specializing in clinical trial management, is joining the Alliance for Regenerative Medicine (ARM).
PRC Clinical, a CRO specializing in clinical trial management, is joining the Alliance for Regenerative Medicine (ARM). PRC Clinical has expertise in stem cell and regenerative research working with sponsors in the United States and Israel. Regenerative Medicine is focused on the development and application of cell-based therapies and related technologies to enhance the natural healing process, and/or replace or regenerate organs and tissues. ARM members include Pfizer, Johnson & Johnson and Novartis.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
